Health Economics / Outcomes Research

(B-178) Accessing the Effectiveness of a Telephonic Medication Adherence Program among Medicare Members

(B-167) Antihypertensive Treatment Persistence and Direct Medical Cost in Acute Coronary Syndrome Patients Post-Percutaneous Coronary Intervention: Insights from Indonesia

(B-162) Artificial Intelligence-Based Estimation of the CGI-I to Address Gaps in Real-World Data and Increase Study Sample Size

(B-176) Catheter ablation versus antiarrhythmic drugs for treatment of atrial fibrillation in patients with concomitant heart failure with preserved ejection fraction (HFpEF)

(B-161) Change in Healthcare Use Before and After COVID-19 Using Data From 1.5 Million Individuals in Sweden

(B-164) Clinical and Cost Impact of Long COVID in the Medicare Population: A Self-Controlled and Propensity Score Matched Case-Control Study

(B-165) Clinical and Economic Burden Associated with Dural Tears Among Patients Undergoing Spinal Discectomy: A Retrospective Database Analysis

(B-172) Comparative Meta-Analysis of the Efficacy and Safety of Targeted Therapy and Immunotherapy Combined with Chemotherapy Versus Conventional Chemotherapy in Recurrent or Metastatic Head and Neck Cancer

(B-180) Comparative Risk of Hip and Knee Arthroplasty Among Medicare Beneficiaries Initiating GLP-1 Receptor Agonists vs. SGLT2 Inhibitors

(B-179) Comparative Risk of Hip Fracture Among Medicare Beneficiaries Initiating GLP-1 Receptor Agonists vs. SGLT2 Inhibitors

(B-182) Cost-effective interventions to prevent prescription drug misuse: a systematic review

(B-159) Do GLP-1 RA medications change the rate of total knee and hip replacement surgeries? Comparing different GLP-1 RA medications as a proxy of their effect

(B-177) Effect of Antihypertensive Medications on Economic Burden Among Alzheimer’s Disease and Related Dementia Medicaid Beneficiaries in South Carolina

(B-166) Employee Care Partners of Spouses with Parkinson's Disease: Analysis of Patient and Care Partner (Direct Medical, Rx, and Total) Costs and Care Partner Lost Work Time

(B-169) Evaluation of completeness of patients’ follow up in a hospital healthcare database by matching with a closed claims database among atrial fibrillation patients

(B-163) Health Utilities in Unresectable Hepatocellular Carcinoma: Subgroups Analyses in the IMbrave150 Trial

(B-175) Impact of Pharmaceutical Care on the Quality-Adjusted Life Years in Diabetic Foot Ulcer Patients - A Randomized Controlled Trial

(B-181) Impact of Serum Creatinine Trajectories Associated with Drug-Related Acute Kidney Injury and Major Adverse Kidney Events in Critically Ill Patients

(B-160) Patient and Prescriber-related factors associated with return to daily-dispense methadone: A multilevel cohort study

(B-173) Prevalence of Symptoms among Self-Reported Interstitial Cystitis Patients: A Longitudinal Study Leveraging an Integrated Database

(B-168) Real-world treatment patterns and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) who received a third line treatment

(B-170) Spending, Utilization, and Price Trends for Anti-Obesity Medications in US Medicaid Programs: A Comprehensive Analysis from 1999 to 2023

(B-183) Systematic Review: Cost-Benefit Analysis of Rivaroxaban Versus Warfarin Using a Decision Tree Model

(B-174) Transcending barriers to pain care in rural America: a pragmatic comparative effectiveness trial of evidence-based, on-demand, digital behavioral treatments for chronic pain